Last reviewed · How we verify

Androgen deprivation treatment — Competitive Intelligence Brief

Androgen deprivation treatment (Androgen deprivation treatment) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hormone antagonist. Area: Oncology.

phase 2 Hormone antagonist Androgen receptors Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Androgen deprivation treatment (Androgen deprivation treatment) — baotai Liang. Androgen deprivation treatment drugs work by reducing the production of androgens, such as testosterone, which can fuel the growth of certain types of cancer.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Androgen deprivation treatment TARGET Androgen deprivation treatment baotai Liang phase 2 Hormone antagonist Androgen receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hormone antagonist class)

  1. baotai Liang · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Androgen deprivation treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/androgen-deprivation-treatment. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: